News

Home > News & Events > Efforts to Rein-in on CRC Foster New Screening & Risk-Assesment Tools

Efforts to Rein-in on CRC Foster New Screening & Risk-Assesment Tools

Efforts to Rein-in on CRC Foster New Screening & Risk-Assesment Tools

Medial EarlySign: Applying Big Data Analytics to Cancer Risk Assessment

A pioneer in algorithm-based Big Data analysis, Medial EarlySign is using its expertise to help identify patients at who are at high risk of CRC and other cancers. But, rather than developing a test that is run directly on blood samples, the company is applying a sophisticated algorithm to data that is readily available in the patient’s medical and insurance records, including data collected from one of the most common tests performed today—the complete blood count (CBC)

 

Download complete article here: The MedTech Strategist